The estimated Net Worth of Paul R Flynn is at least $6.37 Million dollars as of 17 April 2023. Paul Flynn owns over 2,781 units of Dexcom Inc stock worth over $3,568,109 and over the last 3 years Paul sold DXCM stock worth over $2,799,200.
Paul has made over 5 trades of the Dexcom Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Paul sold 2,781 units of DXCM stock worth $333,720 on 17 April 2023.
The largest trade Paul's ever made was selling 8,988 units of Dexcom Inc stock on 8 December 2022 worth over $1,110,018. On average, Paul trades about 1,854 units every 81 days since 2021. As of 17 April 2023 Paul still owns at least 52,112 units of Dexcom Inc stock.
You can see the complete history of Paul Flynn stock trades at the bottom of the page.
Paul's mailing address filed with the SEC is 6340, Sequence Drive, Sorrento Valley, San Diego, San Diego County, California, 92121, United States.
Over the last 19 years, insiders at Dexcom Inc have traded over $724,717,982 worth of Dexcom Inc stock and bought 165,450 units worth $3,489,100 . The most active insiders traders include Sean Carney, Kim D Blickenstaff, and Steven R Altman. On average, Dexcom Inc executives and independent directors trade stock every 7 days with the average trade being worth of $892,438. The most recent stock trade was executed by Sadie Stern on 9 September 2024, trading 426 units of DXCM stock currently worth $29,458.
founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
Dexcom Inc executives and other stock owners filed with the SEC include: